At Caravel Law, Dan works primarily with multi-nationals and SMEs operating in the life sciences industry, pharmaceuticals and medical devices in particular. His experience covers the key stages of technology development from discovery, through clinical development, to sales and marketing and reimbursement.

Dan has reviewed, prepared, and negotiated: in-licensing and out-licensing agreements for brand and generic companies; research agreements between health care institutions, CROs, and developers; supply agreements between distributors, wholesalers, and hospitals; and contract manufacturing agreements for Canadian companies sourcing products from manufacturers in Europe, India, and China.

He can assist your business operating in Canada with:

In-Licensing and Out-Licensing
Clinical Research Agreements
Supply Chain & Contract Manufacturing
PMR & PAAB Disputes
Market Access & Product Listing Agreements
Procurement
Intellectual Property Management
His priority is to understand the opportunities and risks presented by your business model, technology, and market focus and to factor those into developing and providing relevant advice.

He has advised clients such as AbbVie, Allergan, Apotex, AstraZeneca, Bioniche, Daiichi, Janssen, J&J, The Hospital for Sick Children, and Sunnybrook Health Sciences.